Raymond J. Furey

CIK: 0001577899

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RIGL

RIGEL PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

RIGL
RIGEL PHARMACEUTICALS INC
Sep 1, 2026
Tax Payment(F)
Direct
877 shares at avg. $47.50$42K
RIGL
RIGEL PHARMACEUTICALS INC
Jun 17, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
7.4K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Jun 1, 2026
Tax Payment(F)
Direct
877 shares at avg. $29.86$26K
RIGL
RIGEL PHARMACEUTICALS INC
Feb 17, 2026
Award(A)
Direct
19.5K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Feb 10, 2026
Tax Payment(F)
Direct
3.5K shares at avg. $34.62$123K
RIGL
RIGEL PHARMACEUTICALS INC
Feb 2, 2026
Tax Payment(F)
Direct
4K shares at avg. $36.01$143K
RIGL
RIGEL PHARMACEUTICALS INC
Sep 15, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
7.4K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Mar 17, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
9.4K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Mar 17, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
7.9K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Feb 5, 2025
Sale(S)
Direct
1.3K shares at avg. $21.93$29K
RIGL
RIGEL PHARMACEUTICALS INC
Feb 4, 2025
Sale(S)
Direct
1.4K shares at avg. $20.92$30K
RIGL
RIGEL PHARMACEUTICALS INC
Jan 29, 2025
Award(A)
Direct
19.7K shares-

		Type	Shares	Price		Ownership
Sep 1, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	877	$47.50	$41,658	Direct
Jun 17, 2026	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	7,394	-	-	Direct
Jun 1, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	877	$29.86	$26,187	Direct
Feb 17, 2026	RIGL RIGEL PHARMACEUTICALS INC	Award(A)	19,497	-	$0	Direct
Feb 10, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	3,546	$34.62	$122,763	Direct
Feb 2, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	3,968	$36.01	$142,888	Direct
Sep 15, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	7,394	-	-	Direct
Mar 17, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	9,375	-	-	Direct
Mar 17, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	7,850	-	-	Direct
Feb 5, 2025	RIGL RIGEL PHARMACEUTICALS INC	Sale(S)	1,339	$21.93	$29,359	Direct
Feb 4, 2025	RIGL RIGEL PHARMACEUTICALS INC	Sale(S)	1,448	$20.92	$30,294	Direct
Jan 29, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A)	19,717	-	$0	Direct

1-12 of 12 transactions

About Furey Raymond J.

Furey Raymond J. (SEC CIK 0001577899) files insider reports with the SEC as EVP, GC, CCO & Corp Sec of RIGEL PHARMACEUTICALS INC (RIGL).

Signal8 holds 10 ownership filings by Furey Raymond J., all Form 4s, filed between Jan 31, 2025 and Sep 3, 2026. Those filings report 12 transactions, from Jan 29, 2025 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Furey Raymond J.'s filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Furey Raymond J.

Sep 1, 2026: Tax withholding of RIGL shares (Form 4, code F).
Jun 17, 2026: Grant or award of RIGL derivative securities (Form 4, code A).
Jun 1, 2026: Tax withholding of RIGL shares (Form 4, code F).
Feb 17, 2026: Grant or award of RIGL shares (Form 4, code A).
Feb 10, 2026: Tax withholding of RIGL shares (Form 4, code F).

Other insiders filing for RIGEL PHARMACEUTICALS INC (RIGL)

Schorno Dean L, EVP & Chief Financial Officer
Santos David A, EVP, Chief Commercial Officer
RODRIGUEZ RAUL R, CEO, President
HANNAH ALISON L., EVP, Chief Medical Officer
Ali-Jackson Kamil, Director
Rojkjaer Lisa, EVP, Chief Medical Officer

How to read Form 4 transaction codes